Novo Nordisk A/S (NVO)vsTotalEnergies SE ADR (TTE)
NVO
Novo Nordisk A/S
$42.22
+4.79%
HEALTHCARE · Cap: $187.21B
TTE
TotalEnergies SE ADR
$93.60
+1.41%
ENERGY · Cap: $206.57B
Smart Verdict
WallStSmart Research — data-driven comparison
Novo Nordisk A/S generates 68% more annual revenue ($309.06B vs $183.96B). NVO leads profitability with a 33.1% profit margin vs 8.2%. TTE appears more attractively valued with a PEG of 0.78. TTE earns a higher WallStSmart Score of 73/100 (B).
NVO
Buy55
out of 100
Grade: C
TTE
Strong Buy73
out of 100
Grade: B
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 61 in profit
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 44.5%
Large-cap with strong market position
Mega-cap, among the largest globally
Earnings expanding 57.1% YoY
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 20.3%
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Revenue declined 7.6%
Earnings declined 4.7%
3.4% revenue growth
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : NVO
The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.
Bull Case : TTE
The strongest argument for TTE centers on Market Cap, EPS Growth, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bear Case : NVO
The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.
Bear Case : TTE
The primary concerns for TTE are Revenue Growth, Free Cash Flow.
Key Dynamics to Monitor
NVO profiles as a declining stock while TTE is a value play — different risk/reward profiles.
NVO carries more volatility with a beta of 0.27 — expect wider price swings.
TTE is growing revenue faster at 3.4% — sustainability is the question.
TTE generates stronger free cash flow (-1.2B), providing more financial flexibility.
Bottom Line
TTE scores higher overall (73/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novo Nordisk A/S
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
TotalEnergies SE ADR
ENERGY · OIL & GAS INTEGRATED · USA
TotalEnergies SE is a global integrated oil and gas company. The company is headquartered in Paris, France.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?